Rafael Ferreira

Prof. Rafael Ferreira

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2019 in Journal of Photochemistry and Photobiology B: Biology
Verified
Journal Article
Closed access
Carla Andreotti DamanteCarla Andreotti Damante
Carla Andreotti Damante
PKPaula Stephania Brandão Hage Karam
Paula Stephania Brandão Hage Karam
Rafael FerreiraRafael Ferreira
Rafael Ferreira
MRMaria Lúcia Rubo Rezende
Maria Lúcia Rubo Rezende
SGSebastião Luiz Aguiar Greghi
Sebastião Luiz Aguiar Greghi
MZMariana Schutzer Ragghianti Zangrando
Mariana Schutzer Ragghianti Zangrando

15 January 2025 in Dentistry Journal
Verified
Journal Article
Open access
PDF file
Rafael FerreiraRafael Ferreira
Rafael Ferreira
SGSebastião Luiz Aguiar Greghi
Sebastião Luiz Aguiar Greghi
ASAdriana Campos Passanezi Sant'Ana
Adriana Campos Passanezi Sant'Ana
MZMariana Schutzer Ragghianti Zangrando
Mariana Schutzer Ragghianti Zangrando
Carla Andreotti DamanteCarla Andreotti Damante
Carla Andreotti Damante
Background/Objectives: Individuals with Down syndrome (DS) often present with severe periodontal disease at a young age. Adjuvant treatments to scaling and root planing (SRP), such as antimicrobial photodynamic therapy (aPDT), may benefit this population. This study evaluated the effectiveness of aPDT as an adjunct to SRP in individuals with DS. A randomized, double-blind, parallel trial was conducted with 37 individuals with DS. Methods: The test group (aPDT; n = 18) received SRP + aPDT, while the control group (C group; n = 19) received SRP only. For aPDT, a red laser (658 nm; 0.1 W; 2229 J/cm2; 40 s sweeping with optical fiber) combined with methylene blue (MB) (100 µg/mL) was applied across repeated sessions (on days 3, 7, and 14). Clinical parameters, such as plaque index (PI), clinical attachment level (CAL), probing depth (PD), and bleeding on probing (BOP), were recorded at baseline and after 3, 6, and 12 months of treatment. Statistical analyses were performed using parametric and non-parametric tests (p < 0.05). Results: Both treatments promoted improvements in all clinical periodontal parameters (p < 0.05). The aPDT group showed a statistically significant reduction in CAL at 3 months (aPDT = 4.58 mm vs. C = 4.72 mm; p < 0.05) and 12 months (aPDT = 4.59 mm vs. C = 4.84 mm; p < 0.05). Conclusions: aPDT improved periodontal health in the long term through a stable gain in attachment.

26 June 2025 in Dentistry Journal
Verified
Journal Article
Open access
PDF file
HOHigor Henrique Carvalho Oliveira
Higor Henrique Carvalho Oliveira
GCGabriela Moura Chicrala-Toyoshima
Gabriela Moura Chicrala-Toyoshima
Carla Andreotti DamanteCarla Andreotti Damante
Carla Andreotti Damante
Rafael FerreiraRafael Ferreira
Rafael Ferreira
The adjunctive use of antimicrobial photodynamic therapy (aPDT) has been investigated as a promising approach to enhance periodontal therapy. Methylene blue (MB) is the most commonly used photosensitizer due to its favorable characteristics, including a neutral pH and an absorption peak at 660 nm. Due to the considerable heterogeneity among studies and the lack of well-established clinical protocols, this study aims to conduct an integrative review to highlight the effects of MB-mediated aPDT as an adjunct to periodontal treatment. The inclusion criteria were randomized clinical trials that used MB as the PS, published between 2009 and 2024, with a minimum follow-up of three months. Studies included patients with periodontitis treated with SRP alone or in combination with aPDT. Of the 237 studies initially identified, 23 met the eligibility criteria and were included in this integrative review. The risk of bias was evaluated using the Cochrane criteria for randomized controlled trials. Although the included studies reported heterogeneous clinical outcomes, a general trend toward improvement in key periodontal parameters—probing depth, bleeding on probing, clinical attachment level, and plaque index—was observed when MB-mediated aPDT was used as an adjunct to conventional periodontal treatment. However, substantial variability in clinical protocols—including differences in photosensitizer concentration, type of light source, irradiation time, and frequency of application—limited the comparability of results across studies. Despite these methodological inconsistencies, current evidence suggests that MB-mediated aPDT holds promise as an adjunctive approach in periodontal therapy. Nevertheless, due to the clinical heterogeneity and the limited number of studies with long-term follow-up, its overall efficacy remains inconclusive. Further well-designed randomized controlled trials with standardized protocols and subgroup analyses are essential to validate its clinical relevance.

3 July 2021 in Research, Society and Development
Verified
Journal Article
Open access
PDF file
GMGustavo Gonçalves Do Prado Manfredi
Gustavo Gonçalves Do Prado Manfredi
MCMATHEUS CARDOSO
MATHEUS CARDOSO
VSVitor de Toledo Stuani
Vitor de Toledo Stuani
Rafael FerreiraRafael Ferreira
Rafael Ferreira
MZMariana Schutzer Ragghianti Zangrando
Mariana Schutzer Ragghianti Zangrando
ASAdriana Campos Passanezi Sant'Ana
Adriana Campos Passanezi Sant'Ana
Recently, the use of type I collagen obtained from Nile Tilapia (Oreochromis niloticus) was proposed for the treatment of second and third-degree burning lesions and diabetic ulcers due to its occlusive and healing properties. The aim of this report is to describe the use of Nile tilapia skin as an occlusive barrier to protect palatal wounds after the removal of free autogenous soft tissue grafts. Two patients with a deficiency in the height of keratinized mucosa were indicated for treatment with free gingival grafts. The palatal donor area was covered with a Nile tilapia skin, stabilized by sutures. Seven days after surgery, patients returned for post-operative care. Patients’ reported outcomes were investigated by the use of a visual analogue scale and included pain, discomfort, impact on chewing and speaking. Analgesics consumption was also recorded. Standardized photographs were obtained to monitor wound healing. Patients were followed up for 30 days. Patients reported reduced pain levels, with low consumption of analgesics during the first week after surgery. No discomfort or difficulty in chewing or speaking was reported. No complications such as hemorrhage or edema were observed. These findings suggest that the Nile Tilapia skin may be an interesting alternative as an occlusive biological dressing in palatal wounds harvest of free gingival grafts.

1 January 2021 in Journal of Indian Society of Periodontology
Verified
Journal Article
Open access
Rafael FerreiraRafael Ferreira
Rafael Ferreira
AZAdrianaGledys Zink
AdrianaGledys Zink
PSPaulo Sérgio da Silva Santos
Paulo Sérgio da Silva Santos
The purpose of this article is to discuss the clinical management and behavior during periodontal treatment in two patients with fragile X syndrome (FXS) using alternative communication with pictures (ACP). Both patients had a history of previous dental care only possible under general anesthesia. The ACP was used to anticipate the activities to be carried out, promoting ambiance, improving the professional–patient communication, and decreasing the stress of the patient. It was possible to carry out outpatient care without oral sedation and containment/physical restraint in both patients, being surpassed the communicative and behavioral difficulties. These case reports allow us to re-think dental care under general anesthesia or other invasive methods for patients with FXS. Therefore, the ACP is an important mediator tool that can facilitate the insertion and the management of patients with FXS, allowing the dental care outpatient clinic to promote oral health and quality of life for these patients, improving adherence to periodontal treatment and the periodontal maintenance for oral hygiene.

1 January 2025 in Research, Society and Development
Verified
Journal Article
Open access
PDF file
VSVinícius Cezak Santos
Vinícius Cezak Santos
Rafael FerreiraRafael Ferreira
Rafael Ferreira
GAGleyson Kleber do Amaral-Silva
Gleyson Kleber do Amaral-Silva
GPGustavo Silva Pelissaro
Gustavo Silva Pelissaro
EJElerson Gaetti-Jardim Júnior
Elerson Gaetti-Jardim Júnior
EGEllen Cristina Gaetti-Jardim
Ellen Cristina Gaetti-Jardim
Noma, also known as Cancrum oris or gangrenous stomatitis, is an infectious disease of bacterial origin, often in association with other microorganisms, affecting orofacial tissues and manifesting through a sequence of precursors. It begins as necrotizing gingivitis and progresses to necrotizing periodontitis and necrotizing stomatitis. In advanced stages, it can lead to facial mutilations, difficulty in eating, and psychological distress due to social stigma. Untreated, it can result in a mortality rate of up to 90%, mainly due to septicemia, dehydration, and malnutrition. When addressed early, the prognosis is favorable, and by treating its precursors, it is challenging to reach severe stages. The disease is often associated with children in impoverished social conditions, weakened immune systems, and malnutrition, especially in regions with low human development indices, such as sub-Saharan Africa, although some cases have been reported elsewhere. Treatment involves several phases, including debridement of necrotic areas, antibiotics, antimicrobial mouth rinses, and supportive periodontal therapy. Despite its rarity, infection can also occur in developed countries and affect adult patients, sometimes without underlying health conditions. The aim of this article is to report a clinical case of noma in a 31-year-old man, without systemic involvement, who sought treatment at the Maria Aparecida Pedrossian University Hospital in Campo Grande, Mato Grosso do Sul, Brazil, due to swelling in the submental region. After hospitalization, biofilm control and postoperative care, there was a satisfactory improvement in the clinical condition.